American foulbrood is a quarantine disease of the honeybee
Apis mellifera
L. in many countries and contributes greatly to colony losses. We performed a label-free proteomics study of exoprotein fractions produced
in vitro
by
Paenibacillus larvae
reference strains of the ERIC I–IV genotypes. A quantitative comparison was performed of previous studied protein-based virulence factors and many newly identified putative virulence factors. Among the multiple proteases identified, key virulence factors included the microbial collagenase ColA and immune inhibitor A (InhA, an analog of the
Bacillus thuringiensis
protein InhA). Both of these virulence factors were detected in ERICs II–IV but were absent from ERIC I. Furthermore, the different S-layer proteins and polysaccharide deacetylases prevailed in ERICs II–IV. Thus, the expression patterns of these virulence factors corresponded with the different speeds at which honeybee larvae are known to be killed by ERICs II–IV compared to ERIC I. In addition, putative novel toxin-like proteins were identified, including vegetative insecticidal protein Vip1, a mosquitocidal toxin, and epsilon-toxin type B, which exhibit similarity to homologs present in
Bacillus thuringiensis
or
Lysinibacillus sphaericus
. Furthermore, a putative bacteriocin similar to Lactococcin 972 was identified in all assayed genotypes. It appears that
P. larvae
shares virulence factors similar to those of the
Bacillus cereus
group. Overall, the results provide novel information regarding
P. larvae
virulence potential, and a comprehensive exoprotein comparison of all four ERICs was performed for the first time. The identification of novel virulence factors can explain differences in the virulence of isolates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.